Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
TXG holding history
10x Genomics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXG overviewAll 13F holders of TXGFull Q2 2026 holdings
- Shares (Q2 2026)
- 397,868
- Value
- $15.3M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 397,868 | $15.3M | <0.1% | +68,550+20.8% | Added | Holders |
| Q1 2026 | 329,318 | $6.99M | <0.1% | +329,318 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −409,127−100.0% | Sold out | Holders |
| Q4 2023 | 409,127 | $22.9M | 0.1% | −365,959−47.2% | Reduced | Holders |
| Q3 2023 | 775,086 | $32.0M | 0.1% | −481,240−38.3% | Reduced | Holders |
| Q2 2023 | 1,256,326 | $70.2M | 0.2% | +206,237+19.6% | Added | Holders |
| Q1 2023 | 1,050,089 | $58.6M | 0.2% | +1,050,089 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −59,159−100.0% | Sold out | Holders |
| Q1 2022 | 59,159 | $4.50M | <0.1% | −26,483−30.9% | Reduced | Holders |
| Q4 2021 | 85,642 | $12.8M | <0.1% | +36,403+73.9% | Added | Holders |
| Q3 2021 | 49,239 | $7.17M | <0.1% | +7,891+19.1% | Added | Holders |
| Q2 2021 | 41,348 | $8.10M | <0.1% | −320,798−88.6% | Reduced | Holders |
| Q1 2021 | 362,146 | $65.5M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.